Immune reconstitution prevents continuous equine infectious anemia virus replication in an Arabian foal with severe combined immunodeficiency: Lessons for control of lentiviruses

Clinical Immunology

Volumn 101, Issue 2, 2001, Pages 237-247

  Mealey, Robert H ^a   Fraser, Darrilyn G ^a   Oaks, J Lindsay ^a   Cantor, Glenn H ^a   McGuire, Travis C ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Adoptive transfer; CTL; EIAV; Equine; Lentivirus; Lymphocyte engraftment; SCID

Indexed keywords

VIRUS RNA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EQUINE INFECTIOUS ANEMIA VIRUS; HORSE; LENTIVIRINAE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIREMIA; VIRUS REPLICATION;

EID: 0035183580     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2001.5109     Document Type: Article

References (46)

1. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
2. Cytotoxic T lymphocytes specific for the simian immunodeficiency virus
3. Major histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins
4. Reduction of HIV concentration during acute infection: Independence from a specific immune response
5. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes
6. The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets
7. A primary production deficit in the thrombocytopenia of equine infectious anemia
8. Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection
9. A kinase-negative mutation of DNA-PK(CS) in equine SCID results in defective coding and signal joint formation
10. Combined immunodeficiency of Arabian horses: Confirmation of autosomal recessive mode of inheritance
11. Immunofluorescent localization of equine infectious anemia virus in tissue
12. Wild-type equine infectious anemia virus replicates in vivo predominantly in tissue macrophages, not in peripheral blood monocytes
13. Detection and induction of equine infectious anemia virus-specific cytotoxic T-lymphocyte responses by use of recombinant retroviral vectors
14. Equine infectious anaemia virus proteins with epitopes most frequently recognized by cytotoxic T lymphocytes from infected horses
15. Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection
16. Combined (B- and T-lymphocyte) immunodeficiency: A fatal genetic disease in Arabian foals
17. Maintenance of foals with combined immunodeficiency: Causes and control of secondary infections
18. Antiviral, anti-glycoprotein and neutralizing antibodies in foals with equine infectious anaemia virus
19. Identification and genetics of horse lymphocyte alloantigens
20. Joint report of the third international workshop on lymphocyte alloantigens of the horse, Kennett Square, Pennsylvania, 25-27 April 1984
21. At least four MHC class I genes are transcribed in the horse: Phylogenetic analysis suggests an unusual evolutionary history for the MHC in this species
22. Polymorphism of DRA among equids
23. Polymorphism and multiple loci for the horse DQA gene
24. Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses
25. CD8 dimer usage on alpha beta and gama delta T lymphocytes from equine lymphoid tissues
26. Report of the first international workshop on equine leucocyte antigens, Cambridge, UK, July 1991
27. Natural variation of equine infectious anemia virus Gag protein cytotoxic T lymphocyte epitopes
28. Antigenic variation of neutralization-sensitive epitopes of caprine arthritis-encephalitis lentivirus during persistent arthritis
29. Monoclonal antibodies to the equine CD2 T lymphocyte marker, to a pan-granulocyte/monocyte marker and to a unique pan-B lymphocyte marker
30. Aplastic anemia
31. Correction of equine severe combined immunodeficiency by bone marrow transplantation
32. Immunologic reconstitution of foals with combined immunodeficiency
33. Immunotherapy in two foals with combined immunodeficiency, resulting in graft versus host reaction
34. Attempted reconstitution of a foal with primary severe combined immunodeficiency
35. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells
36. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR
37. Viral dynamics in human immunodeficiency virus type 1 infection
38. Immunopathogenesis of equine infectious anemia lentivirus disease
39. Equine retroviruses
40. The immunopathogenesis of equine infectious anemia virus
41. Surface receptors on neutrophils and monocytes from immunodeficient and normal horses
42. Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure
43. T cells selectively infiltrate bone marrow areas with residual haemopoiesis of patients with acquired aplastic anaemia
44. Aplasia after donor lymphocyte infusion (DLI) for CML in relapse after sex-mismatched BMT: Recovery of donor-type haemopoiesis predicted by non-isotopic in situ hybridization (ISH)
45. Graft-vs-host reaction following a single blood transfusion
46. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia